John Bothos

John Bothos has an extensive work experience in the field of clinical development and oncology. John is currently working as the Vice President of Clinical Development at Vividion Therapeutics, Inc. Prior to this, they held various roles at AstraZeneca, including Senior Group Director, Group Director, and Director of Oncology Early Clinical Development. Before joining AstraZeneca, John worked as the Director of Clinical Development at MedImmune. John also has experience working at Johnson & Johnson as an Associate Director of Clinical Oncology and Senior Manager of Clinical Sciences. John started their career at Genentech as a Clinical Scientist and later became an Associate Clinical Scientist. John also worked at GlaxoSmithKline as a Principal Clinical Research Scientist and Senior Clinical Research Scientist. John's early career included a role as a Post-Doctoral Fellow at The Wistar Institute.

John Bothos earned their Bachelor of Science degree in Biology from Rowan University in 1998. John then attended the University of Pennsylvania from 1998 to 2004 and received a PhD in Oncology.